Antibiotic Resistance: the Coming Crisis

• A. Bacteria deliberately mutate their DNA when exposed to antibiotics
• B. Random mutations occur during DNA replication, and some of these may confer resistance ✓
• C. Antibiotics directly rewrite the bacterial genome to produce resistance genes
• D. Bacteria inherit resistance from their parent cells in response to an infection

Why: Mutations arise randomly during DNA replication and are not directed by the environment. When a mutation happens to confer resistance, bacteria carrying it survive antibiotic exposure and multiply, so the resistant trait becomes more common through natural selection.

• A. Doctors intentionally choosing which bacteria to treat
• B. Bacteria with traits that help them survive a stressor reproducing more than those without those traits ✓
• C. Bacteria choosing to share resistance genes with other species
• D. The immune system eliminating all bacteria except the strongest ones

Why: Natural selection means individuals with heritable traits suited to their environment leave more offspring. When antibiotics kill susceptible bacteria, resistant bacteria survive and reproduce, shifting the population toward resistance.

• A. Transduction by bacteriophages only
• B. Horizontal gene transfer, such as conjugation via plasmids ✓
• C. Vertical inheritance from parent to daughter cells
• D. Spontaneous generation of new genes from non-coding DNA

Why: Horizontal gene transfer moves genetic material between bacteria rather than only from parent to offspring. Conjugation, transformation, and transduction can all spread resistance genes, and plasmids carrying multiple resistance genes can move between even distantly related species.

• A. It leaves the surviving bacteria with the most exposure to selective pressure, letting resistant strains gain a larger share of the population ✓
• B. It causes the antibiotic to chemically degrade inside the body
• C. It triggers bacteria to immediately mutate all their genes
• D. It allows the immune system to recover too quickly and become weakened

Why: Incomplete treatment leaves a population where the most resistant or least susceptible bacteria remain and can multiply without competition from the susceptible majority. This allows resistance to become established and spread.

• A. Growing a thicker outer cell wall made of cellulose
• B. Producing enzymes such as beta-lactamases that break down the antibiotic ✓
• C. Converting their DNA into RNA to hide from antibiotics
• D. Forming spores that absorb the antibiotic molecules

Why: Beta-lactamases hydrolyze the beta-lactam ring found in penicillins and cephalosporins, inactivating the drug. Other mechanisms include efflux pumps, altered drug targets, and reduced membrane permeability, but enzymatic destruction is a classic example.

• A. They inhibit protein synthesis by binding the 30S ribosomal subunit
• B. They inhibit synthesis of the bacterial cell wall by interfering with peptidoglycan cross-linking ✓
• C. They disrupt bacterial DNA replication by inhibiting DNA gyrase
• D. They damage the bacterial cell membrane by forming pores

Why: Beta-lactam antibiotics bind penicillin-binding proteins (transpeptidases) that cross-link peptidoglycan strands in the bacterial cell wall. Without intact cell walls, bacteria lyse, especially when growing and remodeling their walls.

• A. Fluoroquinolones
• B. Sulfonamides
• C. Aminoglycosides ✓
• D. Glycopeptides

Why: Aminoglycosides such as gentamicin and streptomycin bind the 30S ribosomal subunit, causing misreading of mRNA and premature termination of translation. Fluoroquinolones target DNA gyrase, sulfonamides block folate synthesis, and glycopeptides like vancomycin block cell wall assembly.

• A. Blocking folic acid synthesis
• B. Inhibiting DNA gyrase and topoisomerase IV ✓
• C. Binding ergosterol in the cell membrane
• D. Inhibiting RNA polymerase

Why: Fluoroquinolones stabilize the complex between DNA and DNA gyrase or topoisomerase IV, preventing DNA supercoiling relief and chromosome separation, which leads to lethal DNA breaks.

• A. Are converted into toxic compounds inside the bacterial cell
• B. Compete with para-aminobenzoic acid (PABA), blocking folate synthesis ✓
• C. Permanently open membrane channels that leak cell contents
• D. Bind bacterial ribosomes irreversibly

Why: Sulfonamides are structural analogs of PABA and competitively inhibit dihydropteroate synthase, blocking the production of dihydrofolate. Bacteria must synthesize folate themselves, unlike humans who obtain it from diet, which gives selective toxicity.

• A. Bacteriostatic agents kill bacteria, while bactericidal agents only stop their growth
• B. Bacteriostatic agents inhibit growth and multiplication, while bactericidal agents actively kill bacteria ✓
• C. Bactericidal agents work only against Gram-positive bacteria
• D. The two terms describe the same mechanism of action

Why: Bacteriostatic antibiotics, such as tetracyclines and macrolides, halt bacterial growth and rely on the host immune system to clear the infection. Bactericidal antibiotics, such as beta-lactams and aminoglycosides, actively kill bacteria.

• A. Transformation ✓
• B. Transduction
• C. Conjugation
• D. Binary fission

Why: Transformation is the uptake of free DNA fragments from the surrounding environment, which can include resistance genes released when other bacteria die or lyse. Transduction relies on bacteriophages as vectors, and conjugation requires direct cell-to-cell contact, so neither matches the description.

• A. They directly kill antibiotic-resistant bacteria without transferring any DNA
• B. They package bacterial DNA and carry it from one bacterium to another during infection ✓
• C. They produce plasmids that replicate independently inside the host cell
• D. They block the uptake of free DNA by competing bacteria

Why: During transduction, bacteriophages accidentally package fragments of a host bacterium's DNA during replication and deliver that DNA to the next bacterial cell they infect. This is a key route by which resistance genes can move between bacteria.

• A. Chromosomal genes located in the bacterial nucleoid
• B. Ribosomal RNA operons
• C. Plasmids ✓
• D. Introns within messenger RNA

Why: Plasmids are small, extrachromosomal circular DNA molecules that often carry multiple resistance genes and can be transferred between cells via conjugation through a pilus. Their ability to replicate independently makes them highly effective vehicles for spreading resistance.

• A. The passing of genes from parent cells to daughter cells during binary fission
• B. The movement of genetic material between organisms that are not parent and offspring ✓
• C. The mutation of genes due to exposure to ultraviolet radiation
• D. The inheritance of traits from a single ancestral lineage

Why: Horizontal gene transfer refers to the exchange of genetic material between organisms within a generation, including between unrelated bacteria. This contrasts with vertical gene transfer, which occurs from parent to offspring and is the usual route by which genes are inherited.

• A. It only occurs in eukaryotic cells, which are rarely treated with antibiotics
• B. It allows resistance to spread rapidly between different bacterial species, not just to offspring ✓
• C. It prevents bacteria from producing any new proteins, limiting their survival
• D. It requires antibiotics to be present before any transfer can happen

Why: Because resistance genes can jump between unrelated bacterial species and strains, resistance can emerge and disseminate far faster than it would through reproduction alone. This makes containment difficult, since resistance can appear in new populations without any direct descent from a resistant ancestor.

• A. Bacteria have stopped evolving, so fewer new drugs are needed
• B. Antibiotics offer low financial returns compared with drugs for chronic conditions, discouraging investment ✓
• C. Regulators have banned all new antibiotic research since the 1990s
• D. Scientists have already discovered every naturally occurring antibiotic

Why: Antibiotics are typically prescribed for short courses and are held in reserve to limit resistance, so they generate far less revenue than drugs for chronic diseases. This economic mismatch has led many large pharmaceutical companies to exit antibiotic development.

• A. The network of pipes used to deliver antibiotics in hospitals
• B. The series of stages a candidate drug passes through, from discovery to clinical approval ✓
• C. The supply chain that transports antibiotics from manufacturers to pharmacies
• D. A list of bacteria currently resistant to existing drugs

Why: In drug development, the pipeline refers to the set of candidate compounds at various stages, from early discovery and preclinical testing through clinical trials and regulatory review. A thin pipeline means few candidates are likely to reach patients in the coming years.

• A. They are always too expensive to manufacture at any scale
• B. They often rediscover known compounds or prove toxic or ineffective in clinical trials ✓
• C. Patients refuse to take any drug that is new
• D. They are automatically blocked by the World Health Organization

Why: A large share of antibiotic candidates are rediscoveries of known molecules, and many others fail due to toxicity, poor pharmacokinetics, or insufficient efficacy in trials. This high attrition rate makes the discovery process slow and risky.

• A. Gram-positive cocci that form chains
• B. Gram-negative bacteria, such as Pseudomonas aeruginosa and Enterobacteriaceae ✓
• C. Mycoplasma species that lack a cell wall
• D. Fungi that infect the skin

Why: Gram-negative bacteria have an outer membrane that blocks many drugs from entering, and they often carry efflux pumps and resistance enzymes. The WHO and other bodies have flagged them as critical priorities for new antibiotics.

• A. Soil samples stopped containing microbes
• B. Most easily cultivated, naturally occurring antibiotic-producing organisms had already been screened by the mid-20th century ✓
• C. Computers were unable to analyze chemical structures
• D. International treaties prohibited screening of natural products

Why: The golden age of antibiotic discovery from the 1940s to 1960s came from screening readily cultured soil microbes, especially Streptomyces. As these easy sources were exhausted and rediscovery rates rose, finding genuinely novel classes became much harder.

• A. Seasonal influenza
• B. Methicillin-resistant Staphylococcus aureus (MRSA) infection ✓
• C. Common cold
• D. Chickenpox

Why: MRSA is a well-known healthcare-associated pathogen that spreads through contact in hospitals and other care settings. It resists beta-lactam antibiotics such as methicillin and its relatives, making infections harder to treat.

• A. Hospitals use fewer antibiotics than the community
• B. Patients are often vulnerable, antibiotic use is frequent, and bacteria can spread easily among patients and staff ✓
• C. Hospital air is sterile, so bacteria cannot survive there
• D. Hospital patients are always healthy and rarely need antibiotics

Why: Hospitals combine immunocompromised patients, heavy antibiotic exposure, invasive devices, and close contact among patients and staff. Together these conditions favor selection for resistant strains and their transmission.

• A. To remove resistant bacteria from the hands and interrupt transmission between patients ✓
• B. To make the skin more resistant to antibiotics
• C. To increase the effectiveness of antibiotics taken orally
• D. To replace the need for infection surveillance

Why: Hands are a major vehicle for transmitting resistant bacteria between patients and surfaces. Proper hand hygiene is one of the most effective measures for preventing healthcare-associated infections and the spread of resistance.

• A. A program that only manufactures new antibiotics
• B. Coordinated efforts to ensure antibiotics are prescribed and used appropriately to improve outcomes and limit resistance ✓
• C. A policy requiring antibiotics to be given to all hospital patients
• D. A method for sterilizing hospital equipment

Why: Antimicrobial stewardship aims to use antibiotics only when needed, with the right drug, dose, and duration. This reduces selection pressure for resistance while preserving treatment effectiveness.

• A. Admitting all patients to shared open wards without isolation
• B. Using contact precautions, such as gowns and gloves, for patients known to carry resistant organisms ✓
• C. Stopping all surveillance testing for resistant bacteria
• D. Allowing visitors to move freely between isolated and non-isolated patients

Why: Contact precautions, including gowns and gloves along with isolation when appropriate, help prevent transmission of resistant organisms from colonized or infected patients to others and to healthcare workers.

• A. To treat individual animals that show signs of bacterial infection only
• B. To promote faster growth and prevent disease in crowded animal populations ✓
• C. To eliminate all bacteria from the animal's gut and skin
• D. To replace vaccines entirely in food-producing animals

Why: Antibiotics have long been used in agriculture both to promote growth and to prevent infections in crowded conditions. This widespread, non-therapeutic use exposes large bacterial populations to antibiotics, which selects for resistant strains.

• A. Only by direct contact with an animal's blood
• B. Through the food chain, water, soil, and direct contact with animals or their waste ✓
• C. Resistance genes cannot move between species
• D. Only through insect bites from farm animals

Why: Resistant bacteria and resistance genes can travel from farms into the environment via manure runoff, contaminated water and soil, and foodborne transmission, as well as through direct handling of animals. Genes can also be passed between different bacterial species.

• A. Prophylactic use
• B. Metaphylactic use ✓
• C. Growth promotion
• D. Vaccination

Why: Metaphylaxis means treating a whole group of animals when disease is detected in some of them. It is considered a legitimate veterinary use, though it still increases selection pressure for resistance across the group.

• A. Manure is sterile and therefore harmless
• B. Manure can carry resistant bacteria and antibiotic residues into soil and waterways ✓
• C. Manure only affects animals, never people or ecosystems
• D. Antibiotics break down instantly once excreted

Why: Animals excrete unabsorbed antibiotics and resistant bacteria in their feces. When manure is spread on fields as fertilizer, these can enter soil and run off into rivers and groundwater, spreading resistance into the wider environment.

• A. Increasing routine antibiotic use to prevent all disease
• B. Improving animal welfare, hygiene, and vaccination while limiting non-therapeutic antibiotic use ✓
• C. Switching all animals to human antibiotics
• D. Stopping all veterinary care for livestock

Why: Reducing reliance on antibiotics through better housing, sanitation, biosecurity, vaccination, and restricting non-therapeutic use lowers selection pressure for resistance while still allowing animals to receive needed treatment.

• A. World Trade Organization
• B. World Health Organization ✓
• C. International Monetary Fund
• D. United Nations Environment Programme

Why: The World Health Organization adopted the Global Action Plan on Antimicrobial Resistance in 2015, asking member states to develop or update national action plans based on its five strategic objectives.

• A. Eliminating all antibiotic use in livestock
• B. Improving awareness and understanding of antimicrobial resistance ✓
• C. Banning the development of new antibiotics
• D. Requiring prescriptions for all over-the-counter medicines

Why: Improving awareness and understanding of AMR is one of the five strategic objectives, alongside surveillance, infection prevention, optimizing antimicrobial use, and investment in research and innovation.

• A. To maximize the profits of pharmaceutical companies
• B. To ensure antibiotics are used appropriately in terms of drug choice, dose, and duration ✓
• C. To replace all antibiotics with vaccines
• D. To increase the number of antibiotic prescriptions written each year

Why: Stewardship programs aim to promote the right drug, dose, route, and duration of treatment, which reduces selection pressure for resistance while improving patient outcomes.

• A. It tracks resistance trends so that policies and treatment guidelines can be informed by real data ✓
• B. It determines the price at which antibiotics are sold
• C. It eliminates the need for hospital infection control
• D. It guarantees that bacteria will stop mutating

Why: Surveillance systems monitor which pathogens are becoming resistant and where, providing the evidence needed to target interventions and detect emerging threats early.

• A. Sharing hospital equipment between patients without cleaning
• B. Practicing good hand hygiene and infection prevention measures ✓
• C. Stopping all vaccination programs
• D. Using antibiotics as a preventive measure for every mild illness

Why: Hand hygiene and infection prevention reduce transmission of resistant bacteria between patients and within communities, lowering the need for antibiotics in the first place.